Octopus AIM VCT 2 (OSEC) Competitors GBX 37 0.00 (0.00%) As of 07/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsBuy This Stock OSEC vs. BGHS, HAN, STS, TMI, SJG, BRK, JAGI, RECI, ARR, and BBHShould you be buying Octopus AIM VCT 2 stock or one of its competitors? The main competitors of Octopus AIM VCT 2 include Boussard & Gavaudan GBP (BGHS), Hansa Investment (HAN), STS Global Income & Growth Trust (STS), Taylor Maritime Investments (TMI), Schroder Japan Trust (SJG), Brooks Macdonald Group (BRK), JPMorgan Asia Growth & Income (JAGI), Real Estate Credit Investments (RECI), Aurora Investment Trust (ARR), and Bellevue Healthcare (BBH). These companies are all part of the "asset management" industry. Octopus AIM VCT 2 vs. Its Competitors Boussard & Gavaudan GBP Hansa Investment STS Global Income & Growth Trust Taylor Maritime Investments Schroder Japan Trust Brooks Macdonald Group JPMorgan Asia Growth & Income Real Estate Credit Investments Aurora Investment Trust Bellevue Healthcare Octopus AIM VCT 2 (LON:OSEC) and Boussard & Gavaudan GBP (LON:BGHS) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends. Does the media favor OSEC or BGHS? In the previous week, Octopus AIM VCT 2's average media sentiment score of 0.00 equaled Boussard & Gavaudan GBP'saverage media sentiment score. Company Overall Sentiment Octopus AIM VCT 2 Neutral Boussard & Gavaudan GBP Neutral Which has more risk & volatility, OSEC or BGHS? Octopus AIM VCT 2 has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Boussard & Gavaudan GBP has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500. Which has better valuation & earnings, OSEC or BGHS? Octopus AIM VCT 2 has higher revenue and earnings than Boussard & Gavaudan GBP. Octopus AIM VCT 2 is trading at a lower price-to-earnings ratio than Boussard & Gavaudan GBP, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOctopus AIM VCT 2£7.45M10.09-£1.34M-£0.66-56.20Boussard & Gavaudan GBP-£12.39M0.00-£18.37M-£1.28N/A Is OSEC or BGHS more profitable? Boussard & Gavaudan GBP has a net margin of 0.00% compared to Octopus AIM VCT 2's net margin of -17.95%. Octopus AIM VCT 2's return on equity of -1.44% beat Boussard & Gavaudan GBP's return on equity.Company Net Margins Return on Equity Return on Assets Octopus AIM VCT 2-17.95% -1.44% -10.46% Boussard & Gavaudan GBP N/A -5.37%-3.34% SummaryOctopus AIM VCT 2 beats Boussard & Gavaudan GBP on 6 of the 8 factors compared between the two stocks. Get Octopus AIM VCT 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for OSEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSEC vs. The Competition Export to ExcelMetricOctopus AIM VCT 2Asset Management IndustryFinancial SectorLON ExchangeMarket Cap£75.14M£1.31B£6.36B£3.06BDividend Yield0.14%4.39%4.19%5.02%P/E Ratio-56.2022.4414.08178.12Price / Sales10.092,525.481,838.00256,798.14Price / Cash3.3360.71127.6027.97Price / Book0.811.462.254.65Net Income-£1.34M£264.35M£1.23B£5.90B7 Day PerformanceN/A1.05%0.38%-0.03%1 Month PerformanceN/A1.76%2.70%6.37%1 Year PerformanceN/A7.35%21.64%60.55% Octopus AIM VCT 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSECOctopus AIM VCT 2N/AGBX 37flatN/AN/A£75.14M£7.45M-56.20N/ABGHSBoussard & Gavaudan GBPN/AN/AN/AN/A£300.90M-£12.39M-1,890.63N/AGap UpHANHansa InvestmentN/AGBX 270+1.9%N/A+21.1%£300.04M£80.86M3.51N/APositive NewsSTSSTS Global Income & Growth TrustN/AGBX 244-0.4%N/A+11.5%£298.86M£20.58M16.286Positive NewsTMITaylor Maritime InvestmentsN/AGBX 0.90+0.1%N/A-21.5%£297.45M£9.25B3.68N/ASJGSchroder Japan TrustN/AGBX 253-0.4%N/A+0.8%£296.52M£60.80M4.96N/APositive NewsDividend CutHigh Trading VolumeBRKBrooks Macdonald Group2.2879 of 5 starsGBX 1,780flatGBX 2,025+13.8%-11.4%£289.34M£129.98M44.73512JAGIJPMorgan Asia Growth & IncomeN/AGBX 390-0.8%N/A+10.6%£285.70M£41.43M7.94N/ARECIReal Estate Credit InvestmentsN/AGBX 127.50-0.4%N/A+4.1%£284.09M£28.71M1.22N/APositive NewsARRAurora Investment TrustN/AGBX 250+0.8%N/A-8.1%£282.82M£55.59M5.55N/ANews CoveragePositive NewsBBHBellevue HealthcareN/AGBX 114.20-1.7%N/A-21.4%£281.45M-£9.60M-17.37N/A Related Companies and Tools Related Companies BGHS Alternatives HAN Alternatives STS Alternatives TMI Alternatives SJG Alternatives BRK Alternatives JAGI Alternatives RECI Alternatives ARR Alternatives BBH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OSEC) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredDrone Company Secures Major Defense Contract Amid Sweeping Policy ShiftOn July 10th, the White House and DoD announced a sweeping new directive to fast-track U.S. drone dominance. ...The Tomorrow Investor | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredOne stock to replace Nvidia"I said 'SELL' before this stock dropped 90%. Today, I'm shouting 'BUY NOW' before it's too late." In 2000,...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thNew China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shif...American Alternative | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Octopus AIM VCT 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Octopus AIM VCT 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
